Cart
0

Atrial Fibrillation Market by Type (Surgical [Maze Surgery and Catheter Ablation] and Non-Surgical [Electric Cardioversion, Pharmacological Drugs, Diagnostic Devices, Mapping and Recording Systems, Cardiac Monitors, Access Devices, and Left Atrial Appendage and Closure Devices]) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Get 20% Free Customization In This Report
LI_16479
Pages: 138
Nov 2016 | 4404 Views
 
Author's : Deepa Tatkare
Tables: 31
Charts: 86
 

The Global Atrial Fibrillation Market size is expected to reach $8,319 million by 2022, growing at a CAGR of 13.0% during the forecast period 2014‐2022. Atrial fibrillation is a rapid or irregular rhythm of the heart that increases the risk of heart, stroke, and other complications, such as discomfort (Angina), pressure, or chest pain which may lead to congestive heart failure. The symptoms of atrial fibrillation include confusion, dizziness, fatigue, and fainting. 

Rise in prevalence of atrial fibrillation in geriatric population, technological advancements, and increase in preference of catheter ablation for cardiac arrhythmia treatment drive the growth of atrial fibrillation market share. However, dearth of skilled professionals and unfavorable preference of pharmaceutical interventions (drugs) over AF treatment devices are expected to hinder the atrial fibrillation market growth.

Global Atrial Fibrillation Market Segmentation

Global Atrial Fibrillation Market Segmentation

Get more information on this report : Request Sample Pages

Segment Review

Catheter ablation is the most commonly used surgical devices for the treatment of cardiac arrhythmias. It is recommended for the treatment of AF when anticoagulant drugs and other medications cannot be administered or tolerated by the patient. Therefore, this segment accounted for the major chunk of the overall market in 2015 and is expected to be the fastest-growing market during the forecast period.

Catheter ablation market, by type, 2015

Catheter ablation market by type 2015

Get more information on this report : Request Sample Pages

Top Investment Pockets in Global Atrial Fibrillation Market

Top Investment Pockets in Atrial Fibrillation Market

Get more information on this report : Request Sample Pages

Geographical Market Snapshot

Geographically, North America region generated the highest revenue in 2015. This is mainly attributed to the presence of refined healthcare infrastructure and high adoption rate of highly advanced technologies in North American countries such as U.S., Canada, and Mexico. Also, emergent markets such as Mexico has witnessed significant investments by government and vendors. Moreover, Asia-Pacific is estimated to be the fastest growing region during the forecast period due to its vast population and different age groups being susceptible to cardiac diseases. In addition, the demand for AF devices is expected to boost due to improvement in healthcare infrastructure and expenditure in the emergent markets (such as India and China) to meet the medical needs in these nations.

Mexico: Atrial Fibrillation Market ($Million), 2014‐2022

Mexico Atrial Fibrillation Market

Get more information on this report : Request Sample Pages

Top Impacting Factors

Top Impacting Factors in Global Atrial Fibrillation Market

Get more information on this report : Request Sample Pages

Rising prevalence of atrial fibrillation in geriatric population

The prevalence and incidences of AF increase with age. According to JAMA Internal Medicine, the prevalence of AF is 2.3% (amongst 40 years old) and 5.9% (older than 65 years). Almost 70% aged 65-85 years have it. 

Technological advancements

Traditionally, catheter ablation was used to treat AF that had certain limitations in reducing the chances of stroke as its efficiency degraded with time. Thus, new line of treatment options such as Watchman device, FIRM ablation, and Convergent procedure were developed and have been successful in reducing the chances of atrial fibrillation in 7580% of the patients. Besides, several companies have taken initiatives to develop efficient approach for treating it. For instance, Medtronic, in 2012, received FDA approval and CE mark for its product “Arctic Front Advance Cardiac Cryoballoon” for the treatment of paroxysmal atrial fibrillation. Moreover, in 2016, Heart Rhythm Society in partnership with Boehringer Ingelheim Pharmaceuticals, Inc. awarded “Atrial Fibrillation (AFib) Quality Improvement (QI) Innovation Grant” to Dr. Mark H. Eckman (MD, University of Cincinnati) and Dr. Steven A. Lubitz (MD, MPH, Massachusetts General Hospital to support research on prevention of stroke and atrial fibrillation. Thus, the persistent development in technology has helped in reducing the risk of stroke and atrial fibrillation in patients.

Increasing preference of catheter ablation for cardiac arrhythmia treatment 

Catheter ablation is useful in the treatment of abnormal heart rhythm, specifically when medications are ineffective. It is a low-risk minimal invasive procedure for cardiac arrhythmias treatment. The catheter ablation device removes the faulty heart tissues that cause irregular heart rhythms. Catheter ablation has rendered 95.0% of success rate in treatment of cardiac arrhythmias. Around 50,000 catheter ablation procedure are performed each year in Germany.

Dearth of skilled professionals

The dearth of skilled professionals (such as electrophysiologists, cardiologists, and technicians) is the major factor that could restrain the market growth. According to the Journal of the American College of Cardiology (JACC), there was a shortage of 660 electrophysiologists and 1,685 general cardiologists in 2014. Also, many professionals who cannot perform procedures using advanced devices (such as advanced ablation catheters) has further hampered the adoption of these devices.

Unfavorable preference to pharmaceutical interventions (drugs) over AF treatment devices

Pharmaceutical interventions (drugs) and medications are often preferred over AF devices specifically due to the high cost of the AF treatment incurred by the patient, which limits the sale of these devices. The use of drugs (such as moricizine and quinidine prolongs) are antiarrhythmic drugs that normalize irregular or abnormal heart rhythm. In addition, new medication therapies based on biotechnology and genomics are expected to further fuel the demand for drugs, thus restraining the demand for AF devices. However,combination of both drugs and devices provide better results in the treatment of cardiac arrhythmias, which can contribute to the market growth.

The report provides comprehensive competitive analysis and profiles of major market players such as Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical, Inc., Medtronic plc, Biotronik SE & Co. KG, Koninklijke Philips N.V., Siemens AG, and AtriCure Inc.

Other players in the atrial fibrillation market are Biosense Webster, Inc., CardioFocus, Inc., CathEffects Inc., CathRx Ltd. EndoPhotonix, Inc., Japan Lifeline Co., Osypka AG, Pioneer Medical Devices AG, GE Healthcare, and TZ Medical, Inc.

ATRIAL FIBRILLATION MARKET KEY BENEFITS:

  • In-depth analysis of the market is conducted based on market estimations of the key segments for the period of 20142022.
  • Comprehensive analysis of factors that drive and restrict the growth of the global atrial fibrillation market is provided in the report.
  • Exhaustive analysis by different segments aids to understand the different aspects of atrial fibrillation that are currently used along with the variants that would gain prominence in the future.
  • Competitive intelligence of leading manufacturers and distributors interprets the competitive scenario across various geographies.
  • Key market players and their strategies are analyzed thoroughly, to predict the competitive outlook of the global atrial fibrillation market share.

ATRIAL FIBRILLATION MARKET SEGMENT:

By Devices

  • Surgical Devices
    • Maze Surgery
    • Catheter Ablation
    • Radiofrequency Catheter Ablation
      • Conventional RF Ablation Catheters
      • Irrigated-tip RF Ablation Catheters
    • Cryoablation
    • Microwave Based Catheter Ablation
    • Laser Based Catheter Ablation
    • Navigational Advanced Mapping Accessories
  • Non-Surgical Devices
    • Electric Cardioversion
    • Diagnostic Catheters 
    • Conventional Diagnostic Catheters
      • Fixed Diagnostic Catheters
      • Steerable Diagnostic Catheters
    • Advanced Diagnostic Catheters
    • Mapping and Recording Systems
    • Cardiac Monitors
    • Access Devices
    • Left Atrial Appendage and Closure Devices
    • Intracardiac Echocardiography (ICE) Systems

By Geography 

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • India
    • China
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Egypt
    • Israel
    • South Africa
    • Rest ofLAMEA

  

 

Chapter: 1. INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2. EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3. MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.3. TOP WINNING STRATEGIES
3.4. PORTERS FIVE FORCES ANALYSIS

3.4.1. Bargaining power of suppliers
3.4.2. Bargaining power of buyers
3.4.3. Threat of new entrants
3.4.4. Competitive rivalry
3.4.5. Threat of substitutes

3.5. MARKET SHARE ANALYSIS, 2015
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rising prevalence of atrial fibrillation in geriatric population
3.6.1.2. Technological advancements
3.6.1.3. Increasing preference of catheter ablation for cardiac arrhythmia treatment

3.6.2. Restraints

3.6.2.1. Dearth of skilled professionals
3.6.2.2. Unfavorable preference to pharmaceutical interventions (drugs) over AF treatment devices

3.6.3. Opportunities

3.6.3.1. Rising awareness of atrial fibrillation
3.6.3.2. Opportunities in emerging countries

Chapter: 4. ATRIAL FIBRILLATION MARKET, BY DEVICES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SURGICAL DEVICES

4.2.1.1. Key market trends
4.2.1.2. Key growth factors and opportunities

4.2.2. Market size and forecast

4.2.2.1. MAZE surgery
4.2.2.2.Catheter ablation

4.3. NON-SURGICAL DEVICES

4.3.1. Key market trends

4.3.1.2. Key growth factors and opportunities

4.3.2. Market size and forecast

4.3.2.1. Electric cardioversion
4.3.2.2. Mapping and recording systems
4.3.2.3. Cardiac monitors
4.3.2.4. Access devices
4.3.2.5. Left Atrial Appendage (LAA) and closure devices
4.3.2.6. Intracardiac echocardiography (ICE) systems

Chapter: 5. ATRIAL FIBRILLATION MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. U.K. market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast

5.4. ASIA PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast
5.4.3.2. India market size and forecast
5.4.3.3. China market size and forecast
5.4.3.4. Australia market size and forecast
5.4.3.5. South Korea market size and forecast
5.4.3.6. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Brazil market size and forecast
5.5.3.2. Argentina market size and forecast
5.5.3.3. Egypt market size and forecast
5.5.3.4. Israel market size and forecast
5.5.3.5. South Africa market size and forecast
5.5.3.6. Rest of LAMEA market size and forecast

Chapter: 6. COMPANY PROFILES

6.1. ABBOTT LABORATORIES

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Business performance
6.1.5. Key strategic moves & developments

6.2. JOHNSON & JOHNSON

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Business performance
6.2.5. Key strategic moves & developments

6.3. ATRICURE, INC.

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Business performance
6.3.5. Key strategic moves & developments

6.4. MICROPORT SCIENTIFIC CORPORATION

6.4.1. Company overview
6.4.2. Company Snapshot
6.4.3. Operating Business Segments
6.4.4. Business Performance
6.4.5. Key strategic moves & developments

6.5. BOSTON SCIENTIFIC CORPORATION

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves & developments

6.6. ST. JUDE MEDICAL, INC.

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves & developments

6.7. MEDTRONIC PLC

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments

6.8. BIOTRONIK SE & CO. KG

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Key strategic moves & developments

6.9. KONINKLIJKE PHILIPS N.V.

6.9.1. Company overview
6.9.2. Philips- SNAPSHOT
6.9.3. Operating business segments
6.9.4. Business performance
6.9.5. Key strategic moves and developments

6.10. SIEMENS AG

6.10.1. Company overview
6.10.2. Siemens Healthcare- SNAPSHOT
6.10.3. Operating business segments
6.10.4. Financial performance
6.10.5. Key strategic moves and developments

List of Tables

TABLE 1. WORLD ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 2. WORLD SURGICAL DEVICES ATRIAL FIBRILLATION MARKET, BY DEVICES TYPE ($MILLION), 2014-2022
TABLE 3. WORLD SURGICAL DEVICES ATRIAL FIBRILLATION MARKET, BY REGION ($MILLION), 2014-2022
TABLE 4. WORLD ATRIAL FIBRILLATION MARKET FOR CATHETER ABLATION ($MILLION), 2014-2022
TABLE 5. WORLD ATRIAL FIBRILLATION MARKET FOR RADIOFREQUENCY CATHETER ABLATION($MILLION), 2014-2022
TABLE 6. WORLD ATRIAL FIBRILLATION MARKET FOR NON-SURGICAL DEVICES, BY TYPE ($MILLION), 2014-2022
TABLE 7. WORLD ATRIAL FIBRILLATION MARKET FOR NON-SURGICAL DEVICES, BY REGION ($MILLION), 2014-2022
TABLE 8. WORLD ATRIAL FIBRILLATION MARKET FOR DIAGNOSTIC CATHETER ($MILLION), 2014-2022
TABLE 9. WORLD ATRIAL FIBRILLATION MARKET FOR CONVENTIONAL DIAGNOSTIC CATHETER ($MILLION), 2014-2022
TABLE 10. WORLD ATRIAL FIBRILLATION MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11. NORTH AMERICA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 12. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 13. EUROPE ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 14. EUROPE ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 15. ASIA PACIFIC ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 16. ASIA PACIFIC ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 17. LAMEA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
TABLE 18. LAMEA ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022
TABLE 19. ABBOTT: COMPANY SNAPSHOT
TABLE 20. ABBOTT: OPERATING SEGMENTS
TABLE 21. J&J: COMPANY SNAPSHOT
TABLE 22. J&J: OPERATING SEGMENTS
TABLE 23. ATRICURE, INC.: COMPANY SNAPSHOT
TABLE 24. ATRICURE: OPERATING SEGMENTS
TABLE 25. MICROPORT: COMPANY SNAPSHOT
TABLE 26. MICROPORT: OPERATING SEGMENTS
TABLE 27. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 28. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 29. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 30. ST. JUDE MEDICAL: OPERATING SEGMENTS
TABLE 31. MEDTRONIC: COMPANY SNAPSHOT

List of Figures

FIGURE 1. ATRIAL FIBRILLATION MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2012 - 2016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. PORTERS FIVE FORCES ANALYSIS
FIGURE 5. MARKET SHARE ANALYSIS, 2015
FIGURE 6. TOP IMPACTING FACTORS: WORLD ATRIAL FIBRILLATION MARKET
FIGURE 7. PREVALENCE OF ATRIAL FIBRILLATION BY AGE, 2012
FIGURE 8. WORLD ATRIAL FIBRILLATION MARKET FOR MAZE SURGERY ($MILLION), 2014-2022
FIGURE 9. WORLD ATRIAL FIBRILLATION MARKET FOR CRYOABLATION ($MILLION), 2014-2022
FIGURE 10. WORLD ATRIAL FIBRILLATION MARKET FOR MICROWAVE BASED CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 11. WORLD ATRIAL FIBRILLATION MARKET FOR LASER BASED CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 12. WORLD ATRIAL FIBRILLATION MARKET FOR NAVIGATIONAL ADVANCED MAPPING ACCESSORIES ($MILLION), 2014-2022
FIGURE 13. WORLD ATRIAL FIBRILLATION MARKET FOR CONVENTIONAL RADIOFREQUENCY CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 14. WORLD ATRIAL FIBRILLATION MARKET FOR IRRIGATED-TIP RADIOFREQUENCY CATHETER ABLATION ($MILLION), 2014-2022
FIGURE 15. WORLD ATRIAL FIBRILLATION FOR ELECTRIC CARDIOVERSION ($MILLION), 2014-2022
FIGURE 16. WORLD ATRIAL FIBRILLATION MARKET FOR FIXED DIAGNOSTIC CATHETERS ($MILLION), 2014-2022
FIGURE 17. WORLD ATRIAL FIBRILLATION MARKET FOR STEERABLE DIAGNOSTIC CATHETERS ($MILLION), 2014-2022
FIGURE 18. WORLD ATRIAL FIBRILLATION MARKET FOR ADVANCED DIAGNOSTIC CATHETERS ($MILLION), 2014-2022
FIGURE 19. WORLD ATRIAL FIBRILLATION MARKET FOR MAPPING AND RECORDING SYSTEMS ($MILLION), 2014-2022
FIGURE 20. WORLD ATRIAL FIBRILLATION MARKET FOR CARDIAC MONITORS ($MILLION), 2014-2022
FIGURE 21. WORLD ATRIAL FIBRILLATION MARKET FOR ACCESS DEVICES ($MILLION), 2014-2022
FIGURE 22. WORLD ATRIAL FIBRILLATION MARKET FOR LEFT ATRIAL APPENDAGE AND CLOSURE DEVICES ($MILLION), 2014-2022
FIGURE 23. WORLD ATRIAL FIBRILLATION MARKET FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS ($MILLION), 2014-2022
FIGURE 24. U.S. ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 25. CANADA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 26. MEXICO ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 27. GERMANY: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 28. FRANCE: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 29. U.K.: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 30. ITALY: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 31. SPAIN: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 32. REST OF EUROPE: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 33. JAPAN: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 34. INDIA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 35. CHINA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 36. AUSTRALIA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 37. SOUTH KOREA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 38. REST OF ASIA-PACIFIC: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 39. BRAZIL: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 40. ARGENTINA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 41. EGYPT: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022
FIGURE 42. ISRAEL: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 43. SOUTH AFRICA: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 44. REST OF LAMEA: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022
FIGURE 45. ABBOTT: NET SALES ($MILLION), 2013-2015
FIGURE 46. ABBOTT: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 47. J&J: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 48. J&J: NET SALES, BY REGION (%), 2015
FIGURE 49. J&J: STRATEGY SHARE (%), 2014-2015
FIGURE 50. ATRICURE: NET SALES ($MILLION), 2013-2015
FIGURE 51. ATRICURE: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 52. ATRICURE: NET SALES, BY REGION (%), 2015
FIGURE 53. ATRICURE: STRATEGY SHARE (%), 2013-2016
FIGURE 54. MICROPORT: NET SALES ($MILLION), 2013-2015
FIGURE 55. MICROPORT: NET SALES, BY PRINCIPAL PRODUCT CATEGORY (%), 2015
FIGURE 56. MICROPORT: NET SALES , BY REGION (%), 2015
FIGURE 57. MICROPORT: STRATEGY SHARE (%), 2013- 2015
FIGURE 58. BOSTON SCIENTIFIC: NET SALES ($MILLION), 2013-2015
FIGURE 59. BOSTON SCIENTIFIC: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIGURE 60. BOSTON SCIENTIFIC: RHYTHM MANAGEMENT NET SALES, BY SUB-SEGMENT (%), 2015
FIGURE 61. BOSTON SCIENTIFIC: NET SALES, BY REGION (%), 2015
FIGURE 62. BOSTON SCIENTIFIC: STRATEGY SHARE (%), 2013-2016
FIGURE 63. ST. JUDE MEDICAL: NET SALES ($MILLION), 2013-2015
FIGURE 64. ST. JUDE MEDICAL: NET SALES, BY PRODUCT CATEGORY (%), 2015
FIGURE 65. ST. JUDE MEDICAL: NET SALES, BY REGION (%), 2015
FIGURE 66. ST. JUDE MEDICAL: STRATEGY SHARE (%), 2014-2016
FIGURE 67. MEDTRONIC: OPERATING SEGMENTS
FIGURE 68. MEDTRONIC: NET SALES ($MILLION), 2014-2016
FIGURE 69. MEDTRONIC: NET SALES, BY SEGMENT (%), 2016
FIGURE 70. MEDTRONIC: CARDIAC AND VASCULAR GROUP NET SALES, BY SUB-SEGMENT (%), 2016
FIGURE 71. MEDTRONIC: NET SALES, BY REGION (%), 2016
FIGURE 72. MEDTRONIC: STRATEGY SHARE (%), 2014- 2016
FIGURE 73. BIOTRONIK: COMPANY SNAPSHOT
FIGURE 74. BIOTRONIK: OPERATING SEGMENTS
FIGURE 75. BIOTRONIK: STRATEGY SHARE (%), 2013-2016
FIGURE 76. PHILIPS: COMPANY SNAPSHOT
FIGURE 77. PHILIPS- OPERATING SEGMENTS
FIGURE 78. PHILIPS-NET SALES ($MILLION), 2013-2015
FIGURE 79. PHILIPS- NET SALES, BY SEGMENT (%), 2015
FIGURE 80. PHILIPS- NET SALES, BY REGION (%), 2015
FIGURE 81. PHILLIPS- STRATEGY SHARE (%), 2015-2016
FIGURE 82. SIEMENS-COMPANY SNAPSHOT
FIGURE 83. SIEMENS: OPERATING SEGMENTS
FIGURE 84. SEIMENS: NET SALES ($MILLION), 2013-2015
FIGURE 85. SEIMENS: NET SALES, BY SEGMENT (%), 2015
FIGURE 86. SEIMENS- NET SALES, BY REGION (%), 2015

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Atrial Fibrillation Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $3690
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo